141 related articles for article (PubMed ID: 34015386)
1. Evaluation of indirect damage and damage saturation effects in dose-response curves of hypofractionated radiotherapy of early-stage NSCLC and brain metastases.
Gago-Arias A; Neira S; Pombar M; Gómez-Caamaño A; Pardo-Montero J
Radiother Oncol; 2021 Aug; 161():1-8. PubMed ID: 34015386
[TBL] [Abstract][Full Text] [Related]
2. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapy.
Chan MKH; Chiang CL
Strahlenther Onkol; 2021 Jul; 197(7):622-632. PubMed ID: 33245378
[TBL] [Abstract][Full Text] [Related]
4. Radiobiological Meta-Analysis of the Response of Prostate Cancer to Different Fractionations: Evaluation of the Linear-Quadratic Response at Large Doses and the Effect of Risk and ADT.
Pardo-Montero J; González-Crespo I; Gómez-Caamaño A; Gago-Arias A
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509320
[TBL] [Abstract][Full Text] [Related]
5. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Flentje M
Radiother Oncol; 2013 Oct; 109(1):13-20. PubMed ID: 24183066
[TBL] [Abstract][Full Text] [Related]
6. Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters.
Borst GR; Ishikawa M; Nijkamp J; Hauptmann M; Shirato H; Bengua G; Onimaru R; de Josien Bois A; Lebesque JV; Sonke JJ
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1596-603. PubMed ID: 20231066
[TBL] [Abstract][Full Text] [Related]
7. Obtaining organ-specific radiobiological parameters from clinical data for radiation therapy planning of head and neck cancers.
Quashie EE; Li XA; Prior P; Awan M; Schultz C; Tai A
Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37903437
[No Abstract] [Full Text] [Related]
8. Optimal Radiation Therapy Fractionation Regimens for Early-Stage Non-Small Cell Lung Cancer.
Liu F; Ververs JD; Farris MK; Blackstock AW; Munley MT
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):829-838. PubMed ID: 37734445
[TBL] [Abstract][Full Text] [Related]
9. Generalized Multi-Hit Model of Radiation-Induced Cell Survival with a Closed-Form Solution: An Alternative Method for Determining Isoeffect Doses in Practical Radiotherapy.
Zhao L; Chen X; Tian J; Shang Y; Mi D; Sun Y
Radiat Res; 2020 Apr; 193(4):359-371. PubMed ID: 32031917
[TBL] [Abstract][Full Text] [Related]
10. A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC).
Strigari L; Benassi M; Sarnelli A; Polico R; D'Andrea M
Med Phys; 2012 Jul; 39(7):4502-14. PubMed ID: 22830782
[TBL] [Abstract][Full Text] [Related]
11. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy.
Klement RJ; Sonke JJ; Allgäuer M; Andratschke N; Appold S; Belderbos J; Belka C; Dieckmann K; Eich HT; Flentje M; Grills I; Eble M; Hope A; Grosu AL; Semrau S; Sweeney RA; Hörner-Rieber J; Werner-Wasik M; Engenhart-Cabillic R; Ye H; Guckenberger M
Radiother Oncol; 2020 Jan; 142():210-216. PubMed ID: 31431371
[TBL] [Abstract][Full Text] [Related]
13. Comparison of hyper- and hypofractionated radiation schemes with IMRT technique in small cell lung cancer: Clinical outcomes and the introduction of extended LQ and TCP models.
Li QW; Qiu B; Wang B; Zhang J; Chen L; Zhou Y; Qin JK; Guo SP; Xie WH; Hui ZG; Liang Y; Guo JY; Wang H; Zhu M; Shen WT; Duan LY; Chen LK; Zhang L; Long H; Wang YM; Liu H
Radiother Oncol; 2019 Jul; 136():98-105. PubMed ID: 31015136
[TBL] [Abstract][Full Text] [Related]
14. Optimal dose and fraction number in SBRT of lung tumours: A radiobiological analysis.
Ruggieri R; Stavrev P; Naccarato S; Stavreva N; Alongi F; Nahum AE
Phys Med; 2017 Dec; 44():188-195. PubMed ID: 28130055
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Three Radiobiological Models in Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer.
Lu JY; Lin Z; Lin PX; Huang BT
J Cancer; 2019; 10(19):4655-4661. PubMed ID: 31528230
[No Abstract] [Full Text] [Related]
16. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.
van Leeuwen CM; Oei AL; Crezee J; Bel A; Franken NAP; Stalpers LJA; Kok HP
Radiat Oncol; 2018 May; 13(1):96. PubMed ID: 29769103
[TBL] [Abstract][Full Text] [Related]
17. Tumor Control Probability Analysis for Single-Fraction Carbon-Ion Radiation Therapy of Early-Stage Non-small Cell Lung Cancer.
Paz AE; Yamamoto N; Sakama M; Matsufuji N; Kanai T
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1551-1559. PubMed ID: 30076985
[TBL] [Abstract][Full Text] [Related]
18. A unified multi-activation (UMA) model of cell survival curves over the entire dose range for calculating equivalent doses in stereotactic body radiation therapy (SBRT), high dose rate brachytherapy (HDRB), and stereotactic radiosurgery (SRS).
Li S; Miyamoto C; Wang B; Giaddui T; Micaily B; Hollander A; Weiss SE; Weaver M
Med Phys; 2021 Apr; 48(4):2038-2049. PubMed ID: 33590493
[TBL] [Abstract][Full Text] [Related]
19. Computed 88% TCP dose for SBRT of NSCLC from tumour hypoxia modelling.
Ruggieri R; Stavreva N; Naccarato S; Stavrev P
Phys Med Biol; 2013 Jul; 58(13):4611-20. PubMed ID: 23771131
[TBL] [Abstract][Full Text] [Related]
20. Tumor control probability in hypofractionated radiotherapy as a function of total and hypoxic tumor volumes.
Chvetsov AV; Hanin LG; Stewart RD; Zeng J; Rengan R; Lo SS
Phys Med Biol; 2021 Jun; 66(12):. PubMed ID: 34030139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
